Medicine
Tpoxx 200 mg capsule
Tpoxx 200 mg capsule is a prescription medicine containing Tecovirimat for oral use, marketed by SIGA Technologies, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Storage and Handling Store TPOXX injection in a refrigerator at 2°C to 8°C…
Key facts
- Active ingredient (INN)
- Tecovirimat
- Brand
- Tpoxx
- Strength
- 200 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 42 capsules
- Marketing authorisation holder
- SIGA Technologies
- Manufacturer
- SIGA Technologies
- Origin register
- US FDA, United States
- Storage
- Storage and Handling Store TPOXX injection in a refrigerator at 2°C to 8°C (36°F to 46°F) Do not freeze. Store capsules in the original bottle at 20°C to 25°C (68°F to 77°F), excursions permitted 15°C to 30°C (59°F to 86°F). Short-term (up to 24 hours) storage and handling at an ambient temperature is acceptable.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AX24 Tecovirimat
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 August 2018
- Identifiers
- RxCUI 2055109, 2055115, 2602126 +1DailyMed set ID fce826ab-4d6a-4139-a2ee-a304a913a253NDC 50072-200Application NDA208627
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 42 capsule in 1 bottle | 50072-200-42 | SIGA Technologies | 31 August 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tecovirimat
Clinical summary
Tecovirimat is an orthopoxvirus VP37 envelope wrapping protein inhibitor indicated for the treatment of human smallpox disease in adults and pediatric patients weighing at least 3 kg, among other approved uses. MedsAcross supplies Tecovirimat for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TecovirimatFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TPOXX prescribing information (SIGA Technologies) · U.S. National Library of Medicine, DailyMed
- Tecovirimat SIGA: European public assessment report (EPAR) · European Medicines Agency
Need Tpoxx 200 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.